TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17021352

Group type: EXPERIMENTAL
Intervention: sunscreen
Number of subjects: 143

Group type: COMPARATOR
Intervention: no sunscreen
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: sun damage
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: sun damage plus AK
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: early AK
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: AK
Number of subjects: 143
Study: 12727038

Group type: EXPERIMENTAL
Intervention: Prompt Sheet (PS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General Information Sheet (GI)
Number of subjects: 60
Study: 11064622

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bupivacaine with fentanyl
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bupivacaine with sufentanil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Epidural PCA with fentanyl
Number of subjects: 12

Group type: COMPARATOR
Intervention: Epidural PCA with sufentanil
Number of subjects: 12
Study: 8736566

Group type: EXPERIMENTAL
Intervention: Verbal memory assessment in older subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonverbal memory assessment in older subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison with younger subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison with older subjects
Number of subjects: 0
Study: 1410168

Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray (2 mg nicotine base, mean 27.8 micrograms/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray (ad libitum use)
Number of subjects: 10
Study: 2581913

Group type: EXPERIMENTAL
Intervention: Serocytol "Muqueuse urinaire"
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31305874

Group type: EXPERIMENTAL
Intervention: Nabiximols (up to 32 sprays daily, containing 86.4 mg tetrahydrocannabinol and 80 mg cannabidiol)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: COMPARATOR
Intervention: Nabiximols and Placebo (both groups)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Nabiximols
Number of subjects: 128
Study: 28899206

Group type: EXPERIMENTAL
Intervention: Augmented acupuncture (LI4, LIV3, EX-HN3, GV20, LU7, KID6, including intradermal needles for sustained treatment)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard acupuncture (LI4, LIV3, EX-HN3, GV20)
Number of subjects: 140
Study: 27418034

Group type: EXPERIMENTAL
Intervention: Fortified cereal (50 g) with 150 ml semi-skimmed milk, consumed daily for 12 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Unfortified cereal (50 g) with 150 ml semi-skimmed milk, consumed daily for 12 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Fortified cereal (50 g) with 150 ml semi-skimmed milk
Number of subjects: 71
Study: 24574869

Group type: EXPERIMENTAL
Intervention: Bitewing radiographs (BW)
Number of subjects: 363
Study: 22699751

Group type: EXPERIMENTAL
Intervention: Lutein (10 mg daily for up to 3 months)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Zeaxanthin (10 mg daily for up to 3 months)
Number of subjects: 22
Study: 20070745

Group type: EXPERIMENTAL
Intervention: Immediate implant placement
Number of subjects: 93
Study: 17592923

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Presence of PME at baseline
Number of subjects: 554

Group type: COMPARATOR
Intervention: Worsening
Number of subjects: 554
Study: 15652164

Group type: EXPERIMENTAL
Intervention: Modified potassium citrate toothpaste with triclosan and zinc citrate (Test)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Existing potassium citrate toothpaste product (Positive Control)
Number of subjects: 56
Study: 11858916

Group type: EXPERIMENTAL
Intervention: Heliox-driven continuous nebulizers (70:30 heliox)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Air with 30% O(2) (control group)
Number of subjects: 36
Study: 9527746

Group type: EXPERIMENTAL
Intervention: Manual Roller Pump (MRP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pressure Infusor Pump (PIP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both pumps
Number of subjects: 30
Study: 7888516

Group type: EXPERIMENTAL
Intervention: Nalbuphine 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Meperidine 25 mg
Number of subjects: 100
Study: 2145718

Group type: EXPERIMENTAL
Intervention: Subunit plasma vaccine against hepatitis B, administered in three injections.
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (no vaccination).
Number of subjects: 1000
Study: 668779

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31567592

Group type: EXPERIMENTAL
Intervention: Saline MDNTP‐US technique
Number of subjects: 96

Group type: COMPARATOR
Intervention: MDNTP‐US technique
Number of subjects: 96
Study: 31601989

Group type: EXPERIMENTAL
Intervention: Nomogram based on prognostic factors (open operation, COPD, intra-operative blood transfusion, tumor location, longer operation time)
Number of subjects: 2469

Group type: EXPERIMENTAL
Intervention: Nomogram predictions
Number of subjects: 2469

Group type: EXPERIMENTAL
Intervention: Calibration curves
Number of subjects: 2469
Study: 28584075

Group type: EXPERIMENTAL
Intervention: Zone model predictive control (AP) system
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sensor augmented pump (SAP) therapy
Number of subjects: 19
Study: 25041849

Group type: EXPERIMENTAL
Intervention: NBI-TUR
Number of subjects: 254

Group type: COMPARATOR
Intervention: WLI-TUR
Number of subjects: 254
Study: 24359765

Group type: EXPERIMENTAL
Intervention: Electrographic LVH (ECG-LVH) diagnosis by strain pattern or Cornell voltage >2.0 mV (women) or >2.4 mV (men)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Electrographic LVH (ECG-LVH) diagnosis
Number of subjects: 303
Study: 21084154

Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 16
Study: 18768293

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17552957

Group type: EXPERIMENTAL
Intervention: Tolterodine extended-release (ER)
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1015
Study: 15228994

Group type: EXPERIMENTAL
Intervention: Amniotic Fluid Index (AFI)
Number of subjects: 537

Group type: COMPARATOR
Intervention: Single Deepest Pocket Technique
Number of subjects: 537
Study: 12169332

Group type: EXPERIMENTAL
Intervention: CLN5 patients
Number of subjects: 5

Group type: COMPARATOR
Intervention: Healthy age‐matched controls
Number of subjects: 5
Study: 9666940

Group type: EXPERIMENTAL
Intervention: 0.025 mg/day transdermal 17 beta‐estradiol
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 0.05 mg/day transdermal 17 beta‐estradiol
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 0.1 mg/day transdermal 17 beta‐estradiol
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 7867109

Group type: EXPERIMENTAL
Intervention: alfentanil 250 micrograms with midazolam approximately 50 micrograms.kg‐1 (Group M)
Number of subjects: 60

Group type: COMPARATOR
Intervention: meperidine 50 mg with diazepam approximately 90 micrograms.kg‐1 (Group D)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 60
Study: 2744064

Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: temazepam 20 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 628532

Group type: EXPERIMENTAL
Intervention: Insulin (20 units NPH and 10 units regular) and diabetic diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 72

Group type: COMPARATOR
Intervention: Neither diet nor insulin
Number of subjects: 72
Study: 29385429

Group type: EXPERIMENTAL
Intervention: Thrombo-embolic event (stroke or systemic embolism)
Number of subjects: 365
Study: 27502812

Group type: EXPERIMENTAL
Intervention: Chair-yoga exercises (CY, n = 20)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CG, n = 15)
Number of subjects: 35
Study: 25454802

Group type: EXPERIMENTAL
Intervention: 3 mg eszopiclone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study: 23126214

Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac p.o. one hour prior to surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical site infiltration with lidocaine and epinephrine
Number of subjects: 0
Study: 20974511

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (uninflated cuff for 30 minutes)
Number of subjects: 78
Study: 18593060

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (4g)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 18
Study: 16189981

Group type: EXPERIMENTAL
Intervention: Nurse-supported breastfeeding promotion
Number of subjects: 0
Study: 12200953

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside-induced hypotension (mean arterial pressure lowered to approximately 50 mmHg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no hypotension, mean arterial pressure kept > 70 mmHg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (hypotensive and control)
Number of subjects: 30
Study: 10795554

Group type: EXPERIMENTAL
Intervention: iopromid (low‐osmolar non‐ionic contrast agent)
Number of subjects: 40

Group type: COMPARATOR
Intervention: iotrolan (blood‐isotone non‐ionic product)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: iopromid
Number of subjects: 40

Group type: COMPARATOR
Intervention: iotrolan
Number of subjects: 40
Study: 8667132

Group type: EXPERIMENTAL
Intervention: Etodolac (300 mg capsules, 2 taken 30 minutes prior to surgery, redosed prn)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Combination of acetaminophen with hydrocodone (not premedicated, prn regimen)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 24
Study: 1653901

Group type: EXPERIMENTAL
Intervention: 1 mg of morphine intraarticularly and saline intravenously (Group 1)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline intraarticularly and 1 mg of morphine intravenously (Group 2)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 0.5 mg of morphine intraarticularly and saline intravenously (Group 3)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 1 mg of morphine and 0.1 mg of naloxone intraarticularly and saline intravenously (Group 4)
Number of subjects: 52
Study: 6687805

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with amethocaine 12‐14 mg plus morphine 1 mg (group II)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spinal anaesthesia with amethocaine 12‐14 mg (group I)
Number of subjects: 24
Study: 30400726

Group type: EXPERIMENTAL
Intervention: Continuous infusion of pantoprazole
Number of subjects: 401

Group type: COMPARATOR
Intervention: Intermittent dosing with pantoprazole
Number of subjects: 401
Study: 29523124

Group type: EXPERIMENTAL
Intervention: Dream School Program (DSP) and Mental Health Support Team (MHST)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dream School Program (DSP) only
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison group (offered DSP intervention in 2018/2019)
Number of subjects: 17
Study: 26905932

Group type: EXPERIMENTAL
Intervention: Task-sharing counselling intervention for maternal depression (details on dosage and duration not available)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Qualitative semi-structured interviews
Number of subjects: 21
Study: 26160062

Group type: EXPERIMENTAL
Intervention: Combined Hemoperfusion + Hemodialysis (HP + HD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Hemodialysis (HD) alone
Number of subjects: 36
Study: 22546716

Group type: EXPERIMENTAL
Intervention: Incorporating 60 g/day whole grains into the diet for 16 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incorporating 60 g/day whole grains into the diet for 8 weeks, doubling to 120 g/day for the following 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 20193253

Group type: EXPERIMENTAL
Intervention: Aminophylline delivered via remote controlled capsule to the small bowel
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aminophylline delivered via remote controlled capsule to the ascending colon
Number of subjects: 12

Group type: COMPARATOR
Intervention: Aminophylline delivered orally (control)
Number of subjects: 12
Study: 18577477

Group type: EXPERIMENTAL
Intervention: Urso treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no urso treatment)
Number of subjects: 12
Study: 16157621

Group type: COMPARATOR
Intervention: VACOP-B for 12 weeks (plus HDS/HDT in case of persistent disease)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: VACOP-B for 8 weeks plus upfront HDS/HDT
Number of subjects: 223
Study: 12233894

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg
Number of subjects: 635

Group type: COMPARATOR
Intervention: Alendronate 10 mg
Number of subjects: 635
Study: 10091757

Group type: EXPERIMENTAL
Intervention: Surgery after receiving 30 gray of RT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 20
Study: 7490141

Group type: EXPERIMENTAL
Intervention: copper-zinc superoxide dismutase (6000 U/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: sodium nitroprusside
Number of subjects: 20
Study: 2258874

Group type: EXPERIMENTAL
Intervention: Individual education
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Team education
Number of subjects: 722

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 722
Study: 6122100

Group type: EXPERIMENTAL
Intervention: GL enzyme (hyaluronidase preparation)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 30879212

Group type: EXPERIMENTAL
Intervention: Enhanced Housing Placement Assistance (EHPA)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 236
Study: 27956016

Group type: EXPERIMENTAL
Intervention: GC Gold Label 9 (GC Corp)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Vitro Molar (DFL)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Maxxion R (FGM)
Number of subjects: 150
Study: 26220945

Group type: EXPERIMENTAL
Intervention: YesB (breakfast, lunch, and dinner)
Number of subjects: 22

Group type: COMPARATOR
Intervention: NoB (lunch and dinner without breakfast)
Number of subjects: 22
Study: 25711716

Group type: EXPERIMENTAL
Intervention: Gentamicin-impregnated collagen sponge
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (excision and marsupialization without gentamicin sponge)
Number of subjects: 50
Study: 21852609

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 260
Study: 19410397

Group type: EXPERIMENTAL
Intervention: Movement restrictions after a single Epley maneuver
Number of subjects: 64

Group type: COMPARATOR
Intervention: Free movements after a single Epley maneuver
Number of subjects: 64
Study: 21070621

Group type: EXPERIMENTAL
Intervention: RSI QuickScan intervention programme
Number of subjects: 638

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 638
Study: 16109909

Group type: EXPERIMENTAL
Intervention: Formal dysphagia screen
Number of subjects: 2532

Group type: COMPARATOR
Intervention: No formal dysphagia screen
Number of subjects: 2532
Study: 12375683

Group type: EXPERIMENTAL
Intervention: nifedipine 10 mg orally every 4 h
Number of subjects: 116

Group type: COMPARATOR
Intervention: no prophylaxis (control)
Number of subjects: 116
Study: 9928780

Group type: EXPERIMENTAL
Intervention: Sufentanil 5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30
Study: 7567428

Group type: EXPERIMENTAL
Intervention: Temporal-signal detection task with feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Temporal-signal detection task without feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection task with 12 s target
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection task with 5, 10, or 15 s targets
Number of subjects: 0
Study: 2268917

Group type: EXPERIMENTAL
Intervention: Shenshao Tongguan Pian (SSTGP)
Number of subjects: 565

Group type: COMPARATOR
Intervention: Dan Qi Pian (control)
Number of subjects: 565
Study: 6107159

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Flurazepam
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 31145173

Group type: EXPERIMENTAL
Intervention: Intravenous propofol 1 to 2 mg/kg pretreatment to deepen anesthesia to BIS<40
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group - intravenous saline pretreatment before PCTG puncture and anesthesia targeted to BIS 40 to 60
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Study group - intravenous propofol 1 to 2 mg/kg pretreatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 30286558

Group type: EXPERIMENTAL
Intervention: α-Lipoic Acid (ALA) 900 mg daily for 10 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 27263400

Group type: EXPERIMENTAL
Intervention: Enhanced messaging emphasizing safe sleep practices for both SIDS risk reduction and suffocation prevention
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Standard messaging emphasizing safe sleep practices recommended by the American Academy of Pediatrics for SIDS risk reduction
Number of subjects: 1194
Study: 24352340

Group type: EXPERIMENTAL
Intervention: udenafil 100 mg/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: amlodipine 10 mg/day
Number of subjects: 29
Study: 22717670

Group type: EXPERIMENTAL
Intervention: CDUS (Colour Duplex Ultrasound) as the first line surveillance tool
Number of subjects: 145

Group type: COMPARATOR
Intervention: CT (Computed Tomography)
Number of subjects: 145

Group type: COMPARATOR
Intervention: CDUS vs CT for measuring residual aneurysm size
Number of subjects: 145
Study: 20029053

Group type: EXPERIMENTAL
Intervention: Video self-modeling (VSM) following speech restructuring treatment
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard maintenance (control group)
Number of subjects: 89
Study: 18721639

Group type: EXPERIMENTAL
Intervention: State worry condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation condition
Number of subjects: 0
Study: 16280763

Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bicalutamide 150 mg + Tamoxifen 10 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bicalutamide 150 mg + Radiotherapy (RT)
Number of subjects: 102
Study: 12442242

Group type: EXPERIMENTAL
Intervention: Hot-water immersion (40-41 degrees C)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison treatment (papain or vinegar)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hot-water immersion vs Comparison treatment
Number of subjects: 25
Study: 10624639

Group type: EXPERIMENTAL
Intervention: Fentanyl 100 micrograms loading dose and 70 micrograms.h‐1 continuous infusion
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Fentanyl 200 micrograms loading dose and 150 micrograms.h‐1 continuous infusion
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: N2O concentrations of 0, 20, 40, and 60 vol%; additionally 75 vol% N2O in the group without fentanyl
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Isoflurane vaporizer settings to maintain median power frequency between 2 Hz and 3 Hz
Number of subjects: 65
Study: 7723650

Group type: EXPERIMENTAL
Intervention: Supramaximal all-out exercise at 149% VO2max (study 1)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Constant intensity exercise at approximately 110% VO2max (study 2)
Number of subjects: 21
Study: 1974686

Group type: EXPERIMENTAL
Intervention: formoterol (12 micrograms inhalation b.i.d.)
Number of subjects: 301

Group type: COMPARATOR
Intervention: salbutamol (200 micrograms inhalation q.i.d.)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: formoterol
Number of subjects: 301

Group type: COMPARATOR
Intervention: salbutamol
Number of subjects: 301
Study: 7426230

Group type: EXPERIMENTAL
Intervention: Hyperbaric solution (10 mg amethocaine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hyperbaric solution (15 mg amethocaine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isobaric solution (10 mg amethocaine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isobaric solution (15 mg amethocaine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypobaric solution (10 mg amethocaine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypobaric solution (15 mg amethocaine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amethocaine 15 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amethocaine 10 mg
Number of subjects: 60
Study: 31163134

Group type: EXPERIMENTAL
Intervention: Large cup‐to‐disc ratio (greater than 0.6)
Number of subjects: 1636

Group type: COMPARATOR
Intervention: No large cup‐to‐disc ratio
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Large cup‐to‐disc ratio
Number of subjects: 1636
Study: 29436314

Group type: EXPERIMENTAL
Intervention: Manual-assisted staff training in positive behaviour support (PBS)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 246
Study: 26826432

Group type: COMPARATOR
Intervention: Standard settings of the Fenwal Amicus Apheresis system (mononuclear cells offset of 1.5 and RBC offset of 5.0)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Modified settings of the Fenwal Amicus Apheresis system (mononuclear cells offset of 1.5 and RBC offset of 6.0)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: A‐ALC < .5 × 10(9) lymphocytes/kg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: A‐ALC ≥ .5 × 10(9) lymphocytes/kg
Number of subjects: 122
Study: 24678066

Group type: EXPERIMENTAL
Intervention: Bipolar diathermy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Muscle patch
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Aneurysm clip
Number of subjects: 27